Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma
Sunitinib with or without surgery for metastatic renal cell carcinoma
Comment: Genetic testing of early breast tumours could allow patients to go without chemo
Comment: PD-1 immunotherapy better than chemo alone as first line lung cancer treatment
Comment: Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Comment: Kidney surgery may be unneeded in many intermediate-risk patients
Genetic testing of early breast tumours could allow patients to go without chemo
PD-1 immunotherapy better than chemo alone as first line lung cancer treatment
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Kidney surgery may be unneeded in many intermediate-risk patients
Cancer treatment in the last 6 months of life: when inaction can outperform action
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers